https://pbs.twimg.com/media/EW8-fTaWAAA5LsU?format=png&name=large
They are in trouble.
ian12, Microsoft aren't interested in this sector. They had a bleepa app in 2011.
https://www.microsoft.com/en-gb/p/dicom-viewer/9wzdncrdt1ml?activetab=pivot:overviewtab
The key is adoption and ease of use.
There were literally hundreds of messaging apps including but WhatsApp won due to forced adoption and ease of use.
Expect volatility until Tom can give us solid news about the future of Bleepa.
Fizzy, Those who like casp (like me), the LTH - have millions of shares. There's no compelling case to buy more.
New investors who want exposure to the oil recovery play have many other choices. CASP isn't giving out the info needed to them to make an informed choice.
Clive deliberately or he's just effing thick won't tell us the financial situation.
1) They've reduced admin costs by 25%. 25% of what? Maybe it was up 33% since the last report
and now it's back to where we all thought it should be.
2) They own their own rigs so costs to drill a shallow is reduced ... so what is it now. We know it was $1.5mil. Considering we need to drill 20 of these ... I'd like to know.
3) Production up to 2000 bopd (nice) but how much are we getting paid for it.
4) Deferring salaries but Oraz Jnr now on the payroll.
Clive isn't technical but he is the CFO and knows exactly what those numbers are. He doesn't want to tell you .... why?
The last RNS should have been just one line.
2000bopd at $20 net is $1.2mil/month free cash ... that's all Clive had to say ... but he didn't ... or can't.
When he does ... this will fly.
Swerves, Baker Hughes have written down $15bn of thier assets
https://www.houstonchronicle.com/business/energy/article/Baker-Hughes-to-write-down-15-billion-of-assets-15196677.php
Why? Because thats what honest companies do. They've assesed the situation and come clean to thier shareholders.
From the RNS
"The Company will announce the satisfaction of all Acquisition Conditions and the definitive timetable in due course. The long stop date for the satisfaction of all Acquisition Conditions is 30 June 2020.
If the Acquisition Conditions are not satisfied by this date, and the date is not extended by agreement between the parties, the Company will not issue the Consideration Shares and the Acquisition will not complete."
I hope CASP do the right thing and cancel the acquisition in June.
Richard, I don't disagree with you that this has bags of potential and should be much higher, but I just can't have capital tied up in share that has been making new lows year on year.
And that is all down to how Clive communicates - whether that's deliberate or he's inept I don't know. He's made this share a never ending nightmare to hold. I don't blame Kuat as he should have been advised by Clive on how to manage AIM shareholders.
I'll give you just one of many example.
A5 RNS in Jan 2020.
"Production has been estimated to have steadily increased to the rate of some 1,500 bopd using a 12 mm choke, with further increases expected."
A5 in last RNS clarifying what happened in Jan.
"Earlier this year, following three attempts at a side-track, the well again flowed, initially at a rate of 1,000 bopd but quickly declined to approximately 100 bopd"
If you are still on speaking terms with that buffoon, ask him about that. It's was a lie to let the Rig owner sell his shares into.
We've added 700bpod yet still stuck at 1700bpod. We just can't seem to break 2k. MJF reporting is full of holes. Sometime they add in 54, 804/5 and then omit them randomly. Still no CPR that will put a floor on the sp. Last year I never thought I'd see 4p again, yet here we are heading back to 2p again. How long before another faceless Kaz seller starts dumping again?
Coffee do you think this is the end game for KSA. No Hajj/Ramadan revenue this year. Drowing in Oil. $110bn paid to US in 2017 and $350bn to be paid till 2027. War in yemen. Vision 2030 D.O.A
No sell off in Aramco yet but Saudi investors won't be pleased with whats going on. I think that will be the first domino.
People are too focused on revenue. This is a tech stock. They never make money in the first few years.
It's all about adoption. You have to give the tech away for free to be adopted in large numbers.
Bleepa being rolled out to PAH is significant. Texrad was never clinically adopted and remained a research tool. So I woudn't compare past poor performance with whats happening right now.
Tech adoption follows the bell curve. PAH are early adopters. The Early and Late Majorty which make up more than half the market will come in due course.
dh42, The Texrad CE mark was a flop because as you know Trevor Brown (30% holder and Non-Exec) was selling down. He was on LSE and Twitter deramping FDBK. He put out a holdings RNS just 5hrs after the CE mark RNS. He also told everyone a placing was coming as he had access to the financials and order book.
He's gone. AR the serial placer is gone. It's a very different company now with Tom & Rory and a new batch of investors ... and a new product.
I was in hospital a few years ago with a broken ankle. X-ray was done pretty much straight away but had to wait for a specialist until late next evening. He probably drove in from another location through the rush hour just to spend 10 mins looking at the x-ray and that I could be discharged. I took up a bed for the whole day when someone with more urgent needs could have had it.
Bleepa cuts out all this waste and FDBK got their foot in the door with the NHS. Anbody can see that the demand for this app will rocket once cost & time saving metrics are made public and are backed with evidence from the NHS.
How do we make money if Bleepa is free or £12 per user per month?
That's the entry level cost. You make money by charging for bespoke workflow features that lets the NHS save real money.
One easy metric is "hospital bed day". There are 150,000 beds in the UK (halved from 300k in the 80's through effeicient care).
One hospital bed costs avg £500/day. So the monthly cost is 2.25 billion.
If efficiency savings through Bleepa can increase that capacity by 10,000 or 7% ( so we only need 140,000 beds to service the same population). That saving is worth 150mil/month to the NHS. If Bleepa were to charge £100mil/month then that deal will be worth it to the NHS (£50mil/month saved).
That's just one metric but it makes the point of how you can build a large MCap company from a £12/month app.
Obvioulsy we only have one NHS Trust at the moment but you can see the potential.
It's more than just a messaging app. With every bespoke feature they add FDBK are eating into the NHS clinical software market. Looking very good for FDBK post covid.
VPN based access is horrible, so after they switch to Bleepa they won't be going back.
https://news.trust.org/item/20200408224752-ropnm/
source : https://www.wsj.com/articles/saudis-take-big-stakes-european-oil-companies-11586382353
https://www.bloomberg.com/news/articles/2020-04-08/saudi-wealth-fund-is-said-to-build-200-million-stake-in-equinor
Whilst scared investors were running to the hills they've been buying up stock on the cheap. It's going to be an interesting ride ahead.
Gaz, Bleepa integrates with existsing NHS systems. With Teams or Whatsapp you'd be double keying the discussion. With WhatsApp you can't even cut & paste so people take photographs of images and patient records.
FDBK were able to do this as they were already in this space with Cadran and spent years integrating Texrad with different systems. They had the know-how.
The feedback I've had from Clinicians is that messaging apps like WhatsApp are ok for messaging and having a chat, discussing rotas & patients etc.
Bleepa however, lets you get clinical work done on your mobile device because of the workflow features.